DYMISTA/ DYLASTINE (Viatris Pty Ltd)
Product name
DYMISTA/ DYLASTINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
167 (255 working days)
Active ingredients
azelastine hydrochloride, fluticasone propionate
Registration type
EOI
Indication
Symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 6 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.